fbpx

Day

februar 4, 2019
CAMBRIDGE, Mass., Feb. 04, 2019 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant (MDR) bacterial infections, today announced the acceptance by the U.S. Food and Drug Administration (FDA) of its Investigational New Drug (IND) application for SPR994,...

Nyheder

Lundbeckfonden støtter yngre forskere med 97 millioner kr.
7. juni 2019
Mælketænder sladrer om et folk der gemte sig i over 30.000 år
6. juni 2019
Mød os på Folkemødet!
29. maj 2019

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge